stella
beta
A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion — Stella
Recruiting
Back to Advanced Solid Tumors With Homozygous MTAP Deletion trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(3 sites)
Hungary
ICON / PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest
Spain
START Rioja, The START Center for cancer research, Logroño
Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid,, Madrid
View full record on ClinicalTrials.gov